ONTO Fertility Lab of Illinois, LLC is a specialized reproductive medicine entity based in Chicago, Illinois. The "Lab" designation in the clinic's legal name and slug signals that this entity operates as an embryology laboratory operation — a distinct organizational structure from a physician-practice IVF clinic. In the Illinois fertility market, laboratory entities may function as standalone laboratory service providers that partner with physician practices, or they may be part of a broader fertility network. Chicago is one of the most active fertility markets in the Midwest and nationally, with a dense concentration of SART-member programs serving patients from across Illinois and neighboring states. For a full overview of Illinois fertility programs, visit the Illinois fertility clinics directory.
Physicians and Clinical Team
As a laboratory-designated entity, ONTO Fertility Lab of Illinois is operationally distinct from the clinical (physician practice) component of IVF care. In the U.S. fertility ecosystem, many ART programs separate their clinical practice entity from their embryology laboratory entity — maintaining distinct billing NPIs for physician services and laboratory technical services. This is a common and regulatory-driven organizational structure that has no adverse impact on patient care.
Patients seeking treatment through an ONTO-affiliated physician practice will receive care from board-certified reproductive endocrinologists who direct the clinical program. The laboratory itself is staffed by certified embryologists — typically with advanced degrees in reproductive biology and credentials through organizations such as the American Board of Bioanalysis (ABB) — who perform oocyte handling, fertilization procedures, embryo culture, biopsy for genetic testing, and cryopreservation.
If you are a patient interacting with this entity, confirm with your referring physician or the clinic's administrative team which physician entity handles your clinical care, and which entity handles billing for laboratory vs. physician services.
Services and Treatments
The embryology laboratory component of an IVF program provides critical technical services:
- ICSI (Intracytoplasmic Sperm Injection) — single-sperm injection for male factor infertility or routine IVF fertilization
- Embryo Culture — extended blastocyst culture in specialized media systems with time-lapse monitoring capability
- Vitrification — ultra-rapid cryopreservation of oocytes and embryos for future use
- Embryo Biopsy for PGT — removal of trophectoderm cells from blastocysts for submission to genetics laboratories for PGT-A and PGT-M analysis
- Frozen Embryo Thaw — warming of vitrified embryos for frozen embryo transfer cycles
- Sperm Processing — density gradient centrifugation, swim-up preparation for IUI and IVF
- Oocyte Handling — denudation, maturity assessment, and preparation for ICSI
- Donor Egg Coordination — thawing of vitrified donor eggs from banks or preparation of fresh donor eggs
The affiliated physician practice supporting this lab will offer the full clinical spectrum including consultations, stimulation monitoring, egg retrieval, and embryo transfer — services that must be performed by licensed physician teams.
Laboratory and Success Rates
Laboratory quality is the most important non-physician variable in IVF success. Key quality indicators for an embryology laboratory include fertilization rates, blastulation rates (the percentage of fertilized eggs that develop to blastocyst), vitrification survival rates, and the rate of successful embryo transfers resulting in clinical pregnancy.
For patients using an entity like ONTO Fertility Lab of Illinois, outcome data reported to the CDC's National ART Surveillance System and SART reflects the program as a whole — encompassing both the physician practice and the laboratory operation. Reviewing this data is essential.
Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
Chicago's fertility patient population is large, diverse, and sophisticated. The Illinois market includes major academic programs (Northwestern, University of Chicago, Rush, Loyola) alongside numerous private practices serving the city and suburbs. Patients in the Chicagoland area have meaningful options, and choosing the right program involves evaluating both the clinical team and the laboratory quality.
The Chicago metropolitan area's extensive public transit system (CTA trains and buses) and suburban Metra rail network make most areas of the city and suburbs accessible for patients attending frequent monitoring appointments. For patients in the western, northern, or southern suburbs, confirming a clinic's monitoring flexibility is important.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Illinois has one of the most comprehensive fertility insurance mandates in the United States. The Illinois Fertility Preservation Act and the state's existing infertility coverage mandate require insurance plans issued in Illinois to cover:
- Fertility treatments including IVF, IUI, and GIFT for patients meeting the clinical definition of infertility
- Medically necessary fertility preservation prior to cancer treatment
- Coverage applies to fully insured Illinois plans; self-insured ERISA plans are exempt
For billing purposes, patients receiving IVF services through a program that separates physician and laboratory entities may receive separate Explanations of Benefits (EOBs) and bills — one from the physician practice and one from the laboratory. Both components may be covered under an Illinois fertility mandate plan, but patients should verify with their insurer that both the clinical practice entity and the laboratory entity are in-network.
Frequently Asked Questions
Why does my IVF program have separate billing from a physician entity and a laboratory entity? This is a common structure in the fertility field. The clinical component (consultations, monitoring, egg retrieval, transfer) is billed under the physician practice's NPI, while technical laboratory services (embryology, ICSI, cryopreservation) are billed under the laboratory entity's NPI. Both may be covered under your fertility benefit — but you should verify in-network status for both entities with your insurer separately.
How do I verify that the laboratory partner my fertility clinic uses is high-quality? Ask your physician directly about the laboratory's CLIA certification status, its embryologist staffing and credentials, its fertilization and blastulation rates, and its vitrification survival rates. Review CDC/SART reporting for the overall program. Accreditation by the College of American Pathologists (CAP) is an additional quality indicator for clinical laboratories.
Does Illinois's IVF mandate cover lab fees separately from physician fees? Illinois-mandated fertility coverage applies to the full cost of covered fertility treatments, including laboratory components. However, the specific in-network determination for each billing entity matters for cost-sharing calculations. Confirm with your insurer that the laboratory entity is contracted with your plan.
What is time-lapse embryo monitoring and does it improve outcomes? Time-lapse systems (such as EmbryoScope) photograph embryos continuously throughout culture, allowing embryologists to observe developmental patterns without disturbing the embryo by removing it from the incubator. Some studies suggest it may improve embryo selection and reduce embryo disruption, though evidence on whether it significantly improves live birth rates is still evolving. It is a common feature of well-equipped contemporary embryology laboratories.